Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn
Research ArticleArticle

THE EFFECTS OF α-METHYL-DOPA AND α-METHYL-META-TYROSINE ON THE METABOLISM OF NOREPINEPHRINE AND SEROTONIN IN VIVO

S. M. HESS, R. H. CONNAMACHER, M. OZAKI and S. UDENFRIEND
Journal of Pharmacology and Experimental Therapeutics November 1961, 134 (2) 129-138;
S. M. HESS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
R. H. CONNAMACHER
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
M. OZAKI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
S. UDENFRIEND
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

α-Methyl-3-hydroxyphenylalanine and L-α-methyl-3,4-dihydroxyphenylalanine are decarboxylase inhibitors in vitro and in vivo. Both compounds deplete endogenous norepinephrine in brains and hearts and serotonin levels in the brains of rats and guinea pigs. Although the levels of serotonin return to normal in less than 24 hours, approximating the return to normal activity of the decarboxylation enzyme, the norepinephrine levels in the heart remain depressed for days longer. This study has shown that biosynthesis of norepinephrine can occur during this period and that the ability of the heart to hold norepinephrine is impaired. The prolonged depletion of norepinephrine for days after its precursor dopamine, and serotonin have returned to normal levels is clearly not related to inhibition of the decarboxylation enzyme. This report further demonstrates that the longlasting effect on norepinephrine is caused by the impairment of the tissues to hold the hormone.

Footnotes

    • Received April 20, 1961.
  • © 1961, by The Williams & Wilkins Company

JPET articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Journal of Pharmacology and Experimental Therapeutics
Vol. 134, Issue 2
1 Nov 1961
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Editorial Board (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
THE EFFECTS OF α-METHYL-DOPA AND α-METHYL-META-TYROSINE ON THE METABOLISM OF NOREPINEPHRINE AND SEROTONIN IN VIVO
(Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics
(Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

THE EFFECTS OF α-METHYL-DOPA AND α-METHYL-META-TYROSINE ON THE METABOLISM OF NOREPINEPHRINE AND SEROTONIN IN VIVO

S. M. HESS, R. H. CONNAMACHER, M. OZAKI and S. UDENFRIEND
Journal of Pharmacology and Experimental Therapeutics November 1, 1961, 134 (2) 129-138;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

THE EFFECTS OF α-METHYL-DOPA AND α-METHYL-META-TYROSINE ON THE METABOLISM OF NOREPINEPHRINE AND SEROTONIN IN VIVO

S. M. HESS, R. H. CONNAMACHER, M. OZAKI and S. UDENFRIEND
Journal of Pharmacology and Experimental Therapeutics November 1, 1961, 134 (2) 129-138;
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

Article

  • CRV431 Decreases Liver Fibrosis and Tumor Development
  • Analysis of Expression of cGMP-Dependent Protein Kinase in Rabbit Heart Cells
  • Spontaneous Locomotor Activity and Pharmacokinetics of Intravenous Methamphetamine and Its Metabolite Amphetamine in the Rat
Show more Article

Articles

  • CRV431 Decreases Liver Fibrosis and Tumor Development
  • Analysis of Expression of cGMP-Dependent Protein Kinase in Rabbit Heart Cells
  • Spontaneous Locomotor Activity and Pharmacokinetics of Intravenous Methamphetamine and Its Metabolite Amphetamine in the Rat
Show more Articles

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics